Connection

Charles Bennett to Clinical Trials, Phase II as Topic

This is a "connection" page, showing publications Charles Bennett has written about Clinical Trials, Phase II as Topic.
  1. Cost-effectiveness model of a phase II clinical trial of a new pharmaceutical for essential thrombocythemia: is it helpful to policy makers? Semin Hematol. 1999 Jan; 36(1 Suppl 2):26-9.
    View in: PubMed
    Score: 0.154
  2. Clinical trials: are they a good buy? J Clin Oncol. 2001 Dec 01; 19(23):4330-9.
    View in: PubMed
    Score: 0.047
  3. Valuing clinical strategies early in development: a cost analysis of allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 1999 Sep; 24(5):555-60.
    View in: PubMed
    Score: 0.040
  4. The effect of reimbursement policies on the management of Medicare patients with refractory ovarian cancer. Semin Oncol. 1999 Feb; 26(1 Suppl 1):40-5.
    View in: PubMed
    Score: 0.039
  5. Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project. Leuk Res. 2007 May; 31(5):599-604.
    View in: PubMed
    Score: 0.016
  6. Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis. Ann Intern Med. 2000 Apr 04; 132(7):566-77.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.